SOUTH SAN FRANCISCO, Calif., Aug. 26, 2024 — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference.
Morgan Stanley 22nd Annual Global Healthcare Conference
Wednesday, September 4th, 2024 at 5:35 PM ET
- Fireside chat with Yujiro S. Hata, Chief Executive Officer, hosted by Judah Frommer, Executive Director, Senior Equity Research Analyst
A live audio webcast of the conference event, as permitted by the conference host, will be available at the “Investors/Events” section of the IDEAYA website at https://ir.ideayabio.com/events and/or through the conference host. A replay of the webcast will be accessible for 30 days following the live event.
